Evofem Biosciences, Inc. Exchange Agreements
9 Contracts & Agreements
- Form of Amendment and Preferred Exchange Agreement (Filed With SEC on December 27, 2023)
- Form of Waiver and Rights Exchange Agreement (Filed With SEC on December 27, 2023)
- Form of Exchange Agreement (Filed With SEC on August 10, 2023)
- Form of Adjuvant Exchange Agreement (Filed With SEC on September 16, 2022)
- Form of Investor Exchange Agreement (Filed With SEC on September 16, 2022)
- Form of Amendment and Exchange Agreement For Equity Line Shares (Filed With SEC on May 5, 2022)
- Form of Amendment and Exchange Agreement For Preferred Stock (Filed With SEC on May 5, 2022)
- Form of Amendment and Exchange Agreement For Existing Notes (Filed With SEC on May 5, 2022)
- Form of Exchange Agreement (Filed With SEC on March 24, 2022)